Injective news today centers on the launch of an onchain index for AI computing costs. INJ trades at $7.82, up 1.48% over the past 24 hours.
Injective launches AI compute index perpetuals
On October 26, Injective said the Super Intelligence Compute Index (SICI) is live on mainnet. The benchmark is tied to the hourly rental cost of five Nvidia GPUs and is paired with a perpetual market. The benchmark assigns 40% to Nvidia's H100 SXM 80GB, followed by 25% to the B200 and 15% to the H200, according to the launch announcement. The perpetual contracts use USDC as margin, allowing traders to take positions with up to 10x leverage.
London-based LO:TECH builds and prices the benchmark using rental listings from compute marketplaces. Injective positions the product as a tool for both sides of the market. The company describes the product as a way for traders to take positions on computing costs and for AI developers and infrastructure providers to hedge their exposure.
Injective also said 47% of its active perpetual markets are tied to real-world assets, with 135 markets spanning equities, foreign exchange, commodities, indices and pre-IPO names. Coverage of the launch has noted limits to the announcement. It does not provide evidence that the new market will attract liquidity, nor does it quantify adoption at launch.
Injective says another onchain product is coming
In the same announcement, Injective said it plans to introduce another onchain financial product in the coming days. The project did not name the product or give a specific launch date.
Regulatory and institutional backdrop
The SICI launch follows a series of institutional steps from the past two weeks. On October 15, CEO Eric Chen, accompanied by the company's general counsel, head of policy, and head of research, met with officials from the White House, the U.S. Securities and Exchange Commission (SEC), and the Commodity Futures Trading Commission (CFTC) in Washington. The discussions focused on tokenization and on-chain finance within the existing U.S. regulatory framework. Those meetings were not an approval, and the rapid price move may have outpaced the actual regulatory progress, increasing near-term volatility.
On October 20, Injective partnered with BDACS, the issuer of KRW1, Korea's first stablecoin fully backed by the Korean won. The collaboration is intended to bring the won-backed stablecoin to onchain real-world asset markets.
ETF developments
Exchange-traded product activity also continues. Canary Capital filed another amended registration statement for its Staked INJ ETF with the SEC. The fund is still unapproved and cannot sell shares until the registration becomes effective. According to CoinMarketCap, Injective CEO Eric Chen stated that a U.S. spot ETF tied to INJ could launch before 2027. Approval timing remains uncertain, and no regulator has confirmed a date.